Estratégias para reduzir a inflamação periférica e o risco de Alzheimer

Com base em pesquisas genómicas que ligam as origens do Alzheimer à inflamação em tecidos periféricos como o intestino, pulmões ou pele, medidas práticas de estilo de vida podem ajudar a conter a inflamação crónica. Estas incluem vacinação, higiene oral, dieta, exercício, controlo de peso e gestão do stress, oferecendo benefícios para a saúde geral em meio a uma ciência em evolução.

Estudos genómicos recentes, incluindo a análise de Cesar Cunha de mais de 85.000 casos de Alzheimer e milhões de células individuais (medRxiv DOI: 10.64898/2026.02.09.26344392), sugerem que o risco de Alzheimer pode começar décadas antes com atividade imunitária elevada em órgãos periféricos em vez do cérebro. Embora a causalidade não esteja provada e a investigação continue, reduzir a inflamação persistente — distinta das respostas benéficas de curto prazo a lesões — é prudente para uma saúde mais ampla, podendo mitigar riscos de cancro, doenças cardíacas, AVCs, artrite, depressão e Alzheimer. Key strategies include: Vaccinations: Shots against shingles (Shingrix reduced dementia by 17% over six years vs. Zostavax), flu, and tuberculosis lower inflammation and dementia odds, aligning with findings on midlife infections. Oral hygiene: Preventing gum disease blocks bacteria from entering the bloodstream, curbing systemic inflammation linked to Alzheimer's and heart issues. Mediterranean diet: Emphasizing fruits, vegetables, beans, nuts, whole grains, fish, and olive oil while limiting red/processed meats supports a healthy gut microbiome and dampens inflammation, promoting longevity. Exercise: Any regular activity, including yoga (per 2024 meta-analysis), reduces inflammation markers, as confirmed by 2021 reviews. Weight management: Combating obesity-related inflammation; GLP-1 drugs like semaglutide (Ozempic) for type 2 diabetes correlate with lower dementia risk, though benefits for non-diabetics and established Alzheimer's are unclear. Stress reduction: Chronic stress fuels inflammation; fostering well-being helps counteract this. Estes hábitos melhoram a saúde física e mental de forma holística, complementando a mudança para estratégias de prevenção de corpo inteiro na investigação do Alzheimer.

Artigos relacionados

Illustration of mutated blood cells entering the brain through the blood-brain barrier, linked to Alzheimer's pathology.
Imagem gerada por IA

Study finds blood-cancer-linked mutations in brain immune cells tied to Alzheimer’s pathology

Reportado por IA Imagem gerada por IA Verificado

Researchers at Boston Children’s Hospital report that mutations commonly associated with clonal blood-cell expansion and some blood cancers were enriched in microglia-like immune cells in Alzheimer’s brains and were also detectable in matched blood samples. The Cell study proposes that age- or injury-related weakening of the blood-brain barrier could allow mutated blood immune cells to enter the brain, potentially amplifying inflammation and contributing to neurodegeneration.

A team of researchers led by Professor Yan-Jiang Wang has published a review arguing that Alzheimer's disease requires integrated treatments targeting multiple factors, not single causes. New drugs like lecanemab and donanemab offer modest benefits by slowing decline, but fall short of reversal. The paper, in Science China Life Sciences, emphasizes genetics, aging, and systemic health alongside amyloid-beta and tau proteins.

Reportado por IA

A study involving 73 people with mild cognitive impairment or early dementia found that tailored treatment plans targeting nutritional deficiencies, infections and other factors led to significant cognitive improvements after nine months. Participants in the intervention group saw their overall cognitive scores rise by 13.7 points, while the control group declined by 4.5 points. The approach combines medical interventions with lifestyle changes like diet, exercise and cognitive training.

Researchers from the Institute for Bioengineering of Catalonia and collaborating institutions report that engineered “supramolecular” nanoparticles restored aspects of blood-brain barrier function in Alzheimer’s-model mice, rapidly lowering brain amyloid-β and producing improvements on behavioral and memory tests.

Reportado por IA Verificado

A University of Florida-led study reported an association between use of the joint-health supplement glucosamine and a higher risk of progressing from mild cognitive impairment to dementia, as well as higher mortality among patients already diagnosed with Alzheimer’s disease and related dementias. The researchers emphasized that the findings do not prove glucosamine causes cognitive decline and said the results should be tested in clinical trials.

Este site usa cookies

Usamos cookies para análise para melhorar nosso site. Leia nossa política de privacidade para mais informações.
Recusar